Literature DB >> 15544485

Pharmacophore modeling and three dimensional database searching for drug design using catalyst: recent advances.

Osman Güner1, Omoshile Clement, Yasuhisa Kurogi.   

Abstract

Perceiving a pharmacophore is the first essential step towards understanding the interaction between a receptor and a ligand. Once a pharmacophore is established, a beneficial use of it is 3D database searching to retrieve novel compounds that would match the pharmacophore. As the 3D searching technology has evolved over the years, it has been effectively used for lead optimization, combinatorial library focusing, as well as virtual high-throughput screening. This paper is an update to the original paper published in this journal earlier: Kurogi, Y, and Guner, O. F. "Pharmacophore Modeling and Three-Dimensional Database Searching for Drug Design Using Catalyst," in Current Medicinal Chemistry, 2001, 8(9), 1035-1055.

Mesh:

Substances:

Year:  2004        PMID: 15544485     DOI: 10.2174/0929867043364036

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  33 in total

1.  QMOD: physically meaningful QSAR.

Authors:  Ajay N Jain
Journal:  J Comput Aided Mol Des       Date:  2010-08-19       Impact factor: 3.686

2.  High-throughput structure-based pharmacophore modelling as a basis for successful parallel virtual screening.

Authors:  Theodora M Steindl; Daniela Schuster; Gerhard Wolber; Christian Laggner; Thierry Langer
Journal:  J Comput Aided Mol Des       Date:  2006-09-29       Impact factor: 3.686

Review 3.  Ligand discovery and virtual screening using the program LIDAEUS.

Authors:  P Taylor; E Blackburn; Y G Sheng; S Harding; K-Y Hsin; D Kan; S Shave; M D Walkinshaw
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

4.  Identification of New Human Malaria Parasite Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors by Pharmacophore and Structure-Based Virtual Screening.

Authors:  Elumalai Pavadai; Farah El Mazouni; Sergio Wittlin; Carmen de Kock; Margaret A Phillips; Kelly Chibale
Journal:  J Chem Inf Model       Date:  2016-03-08       Impact factor: 4.956

5.  Open3DALIGN: an open-source software aimed at unsupervised ligand alignment.

Authors:  Paolo Tosco; Thomas Balle; Fereshteh Shiri
Journal:  J Comput Aided Mol Des       Date:  2011-07-27       Impact factor: 3.686

6.  Discovery and pharmacological characterization of a novel potent inhibitor of diacylglycerol-sensitive TRPC cation channels.

Authors:  T Maier; M Follmann; G Hessler; H-W Kleemann; S Hachtel; B Fuchs; N Weissmann; W Linz; T Schmidt; M Löhn; K Schroeter; L Wang; H Rütten; C Strübing
Journal:  Br J Pharmacol       Date:  2015-05-19       Impact factor: 8.739

7.  Computational ligand-based rational design: Role of conformational sampling and force fields in model development.

Authors:  Jihyun Shim; Alexander D Mackerell
Journal:  Medchemcomm       Date:  2011-05       Impact factor: 3.597

8.  Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons.

Authors:  Hung-Kai Chen; Zhaoping Liu; Anke Meyer-Franke; Jens Brodbeck; Rene D Miranda; James G McGuire; Michael A Pleiss; Zhong-Sheng Ji; Maureen E Balestra; David W Walker; Qin Xu; Dah-eun Jeong; Madhu S Budamagunta; John C Voss; Stephen B Freedman; Karl H Weisgraber; Yadong Huang; Robert W Mahley
Journal:  J Biol Chem       Date:  2011-12-12       Impact factor: 5.157

9.  Identification of novel formyl peptide receptor-like 1 agonists that induce macrophage tumor necrosis factor alpha production.

Authors:  Igor A Schepetkin; Liliya N Kirpotina; Jun Tian; Andrei I Khlebnikov; Richard D Ye; Mark T Quinn
Journal:  Mol Pharmacol       Date:  2008-05-05       Impact factor: 4.436

10.  Deterministic pharmacophore detection via multiple flexible alignment of drug-like molecules.

Authors:  Dina Schneidman-Duhovny; Oranit Dror; Yuval Inbar; Ruth Nussinov; Haim J Wolfson
Journal:  J Comput Biol       Date:  2008-09       Impact factor: 1.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.